Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Y
Alleghany Corp
Y
|
+$70.1M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$64.4M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$41.9M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$40.7M |
| 5 |
Warner Bros
WBD
|
+$37.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$103M |
| 2 |
PLAN
Anaplan, Inc.
PLAN
|
+$89.2M |
| 3 |
ANAT
American National Group, Inc. Common Stock
ANAT
|
+$44M |
| 4 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$33.9M |
| 5 |
MGP
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
|
+$20M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Financials | 13.02% |
| 3 | Healthcare | 11.9% |
| 4 | Consumer Discretionary | 10.28% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARI
476
Apollo Commercial Real Estate
ARI
$889M
| $2.16M | 0.06% |
206,713
+96,062
| +87% | +$1.18M |
|
477
Cavco Industries
CVCO
$4.48B
| $2.16M | 0.06% |
10,999
+4,298
| +64% | +$957K |
|
478
Marvell Technology
MRVL
$213B
| $2.16M | 0.06% |
+49,537
| New | +$2.81M |
|
479
First Financial Bancorp
FFBC
$3.47B
| $2.15M | 0.06% |
+111,028
| New | +$2.31M |
|
480
TJX Companies
TJX
$155B
| $2.15M | 0.06% |
38,523
+6,697
| +21% | +$405K |
|
|
TRTN
481
DELISTED
Triton International Limited
TRTN
| $2.14M | 0.06% |
40,721
+23,336
| +134% | +$1.41M |
|
482
G-III Apparel Group
GIII
$1.43B
| $2.14M | 0.06% |
105,783
+52,992
| +100% | +$1.34M |
|
|
EVBG
483
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $2.14M | 0.06% |
+76,651
| New | +$3.11M |
|
484
GitLab
GTLB
$7.04B
| $2.12M | 0.06% |
39,898
+9,898
| +33% | +$460K |
|
|
ACRE
485
Ares Commercial Real Estate
ACRE
$265M
| $2.12M | 0.06% |
172,954
+107,403
| +164% | +$1.56M |
|
486
CALL
Goldman Sachs
GS
$303B
| $2.11M | 0.06% |
7,100
+4,600
| +184% | +$1.43M |
|
487
Vanguard FTSE Europe ETF
VGK
$31.2B
| $2.11M | 0.06% |
+39,965
| New | +$2.32M |
|
|
INFA
488
DELISTED
Informatica
INFA
| $2.11M | 0.06% |
101,578
-4,611
| -4% | -$91.3K |
|
489
Check Point Software Technologies
CHKP
$13.3B
| $2.1M | 0.06% |
17,232
-27,520
| -61% | -$3.53M |
|
490
Thermo Fisher Scientific
TMO
$233B
| $2.1M | 0.06% |
+3,860
| New | +$2.12M |
|
491
Cooper Companies
COO
$14.9B
| $2.1M | 0.06% |
26,772
+20,532
| +329% | +$1.82M |
|
|
MRC
492
DELISTED
MRC Global
MRC
| $2.09M | 0.05% |
209,411
+1,448
| +0.7% | +$16.1K |
|
493
Capri Holdings
CPRI
$1.55B
| $2.08M | 0.05% |
50,765
+23,373
| +85% | +$1.09M |
|
494
Performance Food Group
PFGC
$16.5B
| $2.08M | 0.05% |
45,229
+13,836
| +44% | +$639K |
|
495
CrowdStrike
CRWD
$195B
| $2.07M | 0.05% |
49,016
+23,956
| +96% | +$1.08M |
|
496
Bally's
BALY
$516M
| $2.06M | 0.05% |
103,994
+26,600
| +34% | +$688K |
|
497
SEI Investments
SEIC
$13.1B
| $2.06M | 0.05% |
38,080
+25,008
| +191% | +$1.41M |
|
|
EB
498
DELISTED
Eventbrite
EB
| $2.05M | 0.05% |
199,794
+148,984
| +293% | +$1.78M |
|
499
Innovative Industrial Properties
IIPR
$1.56B
| $2.05M | 0.05% |
+18,667
| New | +$2.65M |
|
500
Lemonade
LMND
$4.13B
| $2.05M | 0.05% |
112,190
-6,650
| -6% | -$140K |
|
Similar funds
Paul Tudor Jones's Q2 2022 Portfolio in Review
As of Q2 2022, Paul Tudor Jones held 2,681 positions worth $3.81B, down 11% from $4.27B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Paul Tudor Jones deployed $332M of net new capital in Q2 2022, opening 766 new positions and adding to 644 existing holdings. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 327,735 shares worth $47.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Liberty Broadband Class C, an estimated $18.4M trimmed.
- Paul Tudor Jones's largest Q2 2022 buy was Biohaven Pharmaceutical Holding Company Ltd.: 327,735 shares worth $47.8M.
- Paul Tudor Jones added most to Alleghany Corp in Q2 2022, an estimated $70.1M increase.
- Paul Tudor Jones's biggest Q2 2022 reduction was Liberty Broadband Class C, cutting an estimated $18.4M.
- Paul Tudor Jones fully exited Cerner Corp in Q2 2022, selling an estimated $103M.
- Paul Tudor Jones's ten largest holdings make up 10% of its $3.81B portfolio in Q2 2022.
- Paul Tudor Jones opened 766 new positions and closed 638 in Q2 2022.
- Paul Tudor Jones's portfolio value fell 11% quarter-over-quarter to $3.81B.
Based on Tudor Investment Corp's 13F filing for Q2 2022, filed 15 Aug 2022.